© The Author 2006. Published by Oxford University Press.
BRIEF COMMUNICATION |
Rapidly Increasing Incidence of Ocular Non-Hodgkin Lymphoma
Affiliation of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD
Correspondence to: Roxana Moslehi, PhD, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, 6120 Executive Blvd., EPS 8047, Rockville, MD 20852 (e-mail: moslehir{at}mail.nih.gov).
A recent report suggesting that ocular adnexal non-Hodgkin lymphoma (NHL) may be related to Chlamydia psittaci infection underscores the need for reliable epidemiologic data for this malignancy. We examined population-based incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program. During 1992–2001 in the 12 SEER areas, ocular (i.e., eye and adnexa) NHL rates per 100 000 person-years for both sexes were highest among Asians/Pacific Islanders, lower in whites, and lower still in blacks. Incidence increased with advancing age and showed little difference by sex, in contrast to other (extranodal and nodal) NHLs, which occurred predominantly in males. From 1975–2001, there was a rapid and steady increase in incidence of ocular NHL, with annual increases of 6.2% and 6.5% among white males and females, respectively, with no evidence of peaking. By contrast, other NHLs showed evidence of peaking in recent years. The distinctive patterns of ocular NHL call for further studies to identify risk factors and mechanisms, including the potential role of C. psittaci or other infections.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Stefanovic and I. S. Lossos Extranodal marginal zone lymphoma of the ocular adnexa Blood, July 16, 2009; 114(3): 501 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Esmaeli, P. McLaughlin, B. Pro, F. Samaniego, I. Gayed, F. Hagemeister, J. Romaguera, F. Cabanillas, S. S. Neelapu, R. Banay, et al. Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma Ann. Onc., April 1, 2009; 20(4): 709 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Sjo, S. Heegaard, J. U. Prause, B. L. Petersen, S. Pedersen, and E. Ralfkiaer Extranodal Marginal Zone Lymphoma in the Ocular Region: Clinical, Immunophenotypical, and Cytogenetical Characteristics Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 516 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Sjo, E. Ralfkiaer, J. U. Prause, J. H. Petersen, J. Madsen, N. T. Pedersen, and S. Heegaard Increasing Incidence of Ophthalmic Lymphoma in Denmark from 1980 to 2005 Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3283 - 3288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. M. Ferreri, R. Dolcetti, M.-Q. Du, C. Doglioni, A. Giordano Resti, L. S. Politi, C. De Conciliis, J. Radford, F. Bertoni, E. Zucca, et al. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy Ann. Onc., May 1, 2008; 19(5): 835 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M L Cohen, J. Sweetenham, and A. D Singh Ocular adnexal lymphoma. What is the evidence for an infectious aetiology? Br J Ophthalmol, April 1, 2008; 92(4): 446 - 448. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zucca and F. Bertoni Chlamydia or not Chlamydia, that is the question: which is the microorganism associated with MALT lymphomas of the ocular adnexa? J Natl Cancer Inst, October 4, 2006; 98(19): 1348 - 1349. [Full Text] [PDF]
|
|